Cover Image

Successful treatment of linear immunoglobulin A bullous dermatosis with dupilumab in a pediatric patient

Saved in:

Bibliographic Details
Main Authors:	Nouf Almuhanna, MD (Author), Rasha Alhamazani, MD (Author), Sarah Alkhezzi, MD (Author), Mahdi T. Alfataih, MD (Author), Salman Al-Malki, MD (Author), Anwar R. Alrashidi, MD (Author), Faris A. Alhomida, MD (Author)
Format:	Book
Published:	Elsevier, 2023-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Successful treatment of dissecting cellulitis with certolizumab pegol in a pregnant patient
by: Nouf Almuhanna, MD, et al.
Published: (2023)

Assessing the use of dupilumab in a pediatric patient with bullous congenital ichthyosiform erythroderma
by: Nouf Almuhanna, MD, et al.
Published: (2023)

Letter in reply: Linear IgA bullous dermatosis treated with dupilumab in a pediatric patient with glucose-6-phosphate dehydrogenase deficiency
by: Sonal Muzumdar, MD, et al.
Published: (2024)

A rare presentation of multiple eruptive vellus hair cysts and dystrophic nails in a pediatric patient with Stüve-Wiedemann syndrome
by: Nouf Almuhanna, MD, et al.
Published: (2023)

A rare presentation of asymmetric limb hypertrophy and diffuse capillary malformations in a pediatric patient with Loeys-Dietz syndrome type 3
by: Nouf Almuhanna, MD, et al.
Published: (2024)

Linear Immunoglobulin a Bullous Dermatosis in Children
by: Francesca Mori, et al.
Published: (2022)

Linear IgA bullous dermatosis preceding a diagnosis of Crohn's disease
by: Nakisa B. Sadeghi, MPH, et al.
Published: (2023)

Linear immunoglobulin A bullous dermatosis with severe ocular sequela
by: Meng-Han Shen, et al.
Published: (2020)

Development of cyclosporine-induced linear IgA bullous dermatosis despite concurrent use of dapsone
by: Karissa Libson, BA, et al.
Published: (2023)

Combined dapsone and sulfapyridine for the treatment of therapy-resistant linear IgA bullous dermatosis: Two case reports
by: Laura Krogh Herlin, MD, et al.
Published: (2022)

Immunologic overlap in a case of linear IgG/IgA bullous dermatosis responsive to rituximab
by: Dmitry Nedosekin, PhD, et al.
Published: (2021)

Dupilumab in acquired perforating dermatosis: A potential new treatment
by: Musaed M. Alsebayel, MD, et al.
Published: (2022)

Revisiting the "jelly-roll" technique: New utility in diagnosing linear IgA bullous dermatosis mimicking toxic epidermal necrolysis
by: Samavia Khan, BS, et al.
Published: (2023)

Linear IgA bullous dermatosis induced by nemvaleukin alfa, an engineered interleukin 2 molecule, in a patient with treatment-refractory metastatic melanoma
by: Fatima Bawany, MD, et al.
Published: (2023)

A Rare Case of Vancomycin-Induced Linear Immunoglobulin A Bullous Dermatosis
by: Pinky Jha, et al.
Published: (2017)

Recalcitrant bullous pemphigoid responsive to dupilumab in an adolescent patient
by: Albert E. Zhou, MD, PhD, et al.
Published: (2022)

A case of linear IgA bullous dermatosis in a glucose-6-phosphate dehydrogenase-deficient child successfully treated with oral erythromycin and topical tacrolimus
by: Michelle Ann Ramos, MD, et al.
Published: (2023)

Toxic epidermal necrolysis-like linear IgA bullous dermatosis after third Moderna COVID-19 vaccine in the setting of oral terbinafine
by: Joseph Han, BS, et al.
Published: (2022)

Toxic epidermal necrolysis-like linear IgA bullous dermatosis as a manifestation of multiple drug hypersensitivity in the setting of drug reaction with eosinophilia and systemic symptoms
by: Scott Stratman, MD, MPH, et al.
Published: (2024)

Immunoglobulin M bullous pemphigoid: An enigma
by: Rosalie Baardman, MD, et al.
Published: (2020)

Radiotherapy-induced localized bullous pemphigoid with a favorable response to dupilumab
by: Chanidapa Wongtada, MD, et al.
Published: (2024)

Heparin-induced bullous hemorrhagic dermatosis: A report of 3 cases
by: Madeline R. Frizzell, MS, et al.
Published: (2020)

Intravenous immunoglobulin-induced eczematous dermatitis treated with dupilumab
by: Katelyn Singh, MD, et al.
Published: (2024)

Dapsone-responsive inflammatory dermatitis with features of subcorneal pustular dermatosis and bullous pemphigoid
by: Shilpa Ghatnekar, MS, et al.
Published: (2022)

Linear IgA bullous dermatosis
by: L. F. Znamenskaya, et al.
Published: (2019)

IgA LINEAR BULLOUS DERMATOSIS IN CHILDHOOD.
by: Ivelina Yordanova, et al.
Published: (2015)

Rituximab for linear IgA bullous dermatosis
by: Rummit Dhillon, et al.
Published: (2022)

Can't handle the itch? Refractory immunotherapy-related transient acantholytic dermatosis: prompt resolution with dupilumab
by: Eva Shelton, BS, et al.
Published: (2022)

Treatment efficacy of dupilumab in a hyper-immunoglobulin E syndrome patient with severe atopic dermatitis
by: Chia-Jui Su, MD, et al.
Published: (2021)

Linear IgA and IgG bullous dermatosis
by: Karina de Almeida Pinto Fernandes, et al.
Published: (2016)

Research progress on linear IgA bullous dermatosis
by: Mei WU, et al.
Published: (2023)

A case of linear IgA bullous dermatosis successfully treated with omalizumab
by: Nayankumar H Patel, et al.
Published: (2020)

VANCOMYCIN-INDUCED LINEAR IGA BULLOUS DERMATOSIS WITH ISOMORPHIC RESPONSE
by: Tatsuhiko Mori, et al.
Published: (2013)

Linear IGA bullous dermatosis in Tunisian children : 31 cases
by: Kharfi Monia, et al.
Published: (2011)

Linear IgA bullous dermatosis: report of an exuberant case
by: Beatriz Cavalcanti de Souza, et al.
Published: (2013)

Unusual clinicopathological and immunological presentation of chronic bullous dermatosis of childhood (linear IgA dermatosis)
by: Al-Saif Fahad, et al.
Published: (2011)

Recalcitrant infantile bullous pemphigoid successfully treated with cyclosporine
by: Efrat Bar-Ilan, MD, et al.
Published: (2022)

Adult linear IgA bullous dermatosis: report of three cases
by: Taila Yuri Siqueira Machado, et al.
Published: (2018)

Letter in response to the case report: "Recalcitrant generalized granuloma annulare treated successfully with dupilumab"
by: Claudia Paganini, MD, et al.
Published: (2023)

Acquired perforating dermatosis associated with risankizumab
by: Munira Alhadlg, MD, et al.
Published: (2024)